Plecstatin-1
Based on 1 publication(s) in Google Scholar
Plecstatin‑1 is a metal complex that drives the aggregation and collapse of the plectin network, and disrupts the cytoskeletal structures of α‑tubulin and F‑actin. Plecstatin-1 triggers oxidative stress, mediates the phosphorylation of eIF2α, and induces molecular features associated with immunogenic cell death, including calreticulin membrane exposure, membrane localization of HSP70/HSP90, ATP secretion, and HMGB‑1 release. Plecstatin-1 induces apoptosis via the intrinsic mitochondrial pathway and exerts anti-invasive activity. Plecstatin‑1 inhibits sphere proliferation and reduces clonogenicity in the 3D tumor spheroid model of colon cancer cells. Plecstatin-1 is applicable to relevant research on colorectal cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2119725-22-1
- Formel: C22H23Cl2FN2RuS
- Molecular Weight:538.47
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Plecstatin-1
MoreAlle Caspase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
α-Tubulin |
eIF2-α |
HSP70 |
HSP90 |
Caspase 3 |
In Vitro
Plecstatin-1 inhibits the growth of HCT-116, HCT-15 and HT-29 colon cancer cells in both 2D monolayer and 3D spheroid models. Its potency is lower in the spheroid model, and its effects on spheroid size and morphology are cell line-dependent[1].
Plecstatin-1 (200 μM; 72 h) reduces the proliferative capacity of HCT-116 colon cancer spheroids[1].
Plecstatin-1 (7 days) reduces the long-term proliferation capacity of HCT-116 and HT-29 colon cancer cell monolayers, as evidenced by decreased colony formation at its IC50 concentration[1].
Plecstatin-1 (50 μM; 15 min-6 h) only weakly interacts with pUC19 plasmid DNA in a cell-free system, indicating that DNA damage is not its primary mechanism of action[1].
Plecstatin-1 (400 μM; 5 days) preferentially accumulates in the proliferative peripheral cells of HT-29 and HCT-116 colon cancer spheroids, with limited uptake by quiescent inner cells[1].
Plecstatin-1 (200 μM; 72 h) disrupts the cytoskeletal structures of plectin, α-tubulin and F-actin in HCT-116 colon cancer spheroids, while exerts weaker effects in HT-29 spheroids[1].
Plecstatin-1 (40 μM; 72 h) reduces the invasiveness of HT1080 fibrosarcoma spheroids in Matrigel invasion assays[1].
Plecstatin-1 (200 μM; 24 h) induces phosphorylation of the stress regulator eIF2α in HCT-116 colon cancer spheroids[1].
Plecstatin-1 (200 μM; 24 h) induces CRT translocation to the plasma membrane of HCT-116, HCT-15 and HT-29 colon cancer spheroids; it also induces ATP secretion from HCT-116 and HT-29 colon cancer spheroids, with the strongest effect observed in HCT-116 spheroids[1].
Plecstatin-1 (200 μM; 72 h) induces HMGB-1 release from HCT-116 and HT-29 colon cancer spheroids, with a stronger effect observed in HCT-116 spheroids[1].
Plecstatin-1 (200 μM; 24 h) increases the levels of HSP70 and HSP90 and promotes their translocation to the plasma membrane of colon cancer spheres[1].
Plecstatin‑1 (200 μM; 72 h) induces mild apoptosis in HCT‑116 and HCT‑15 colon cancer spheroids, but exerts no significant effect on apoptosis in HT‑29 spheroids[1].
Plecstatin-1 (200 μM; 48-72 h) induces apoptosis in HCT-116 colon cancer spheroids via the intrinsic mitochondrial pathway, as evidenced by cytochrome c release and caspase-3 cleavage[1].
Plecstatin-1 (200 μM; 24 h) induces oxidative stress in HCT-116, HCT-15 and HT-29 colon cancer spheroids, with the most potent effect observed in HCT-116 spheroids, and ROS localizes to proliferative peripheral cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT-116 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:72 h
-
Result:Caused an approximately 3-fold decrease in the number of KI67+ cells compared to untreated controls.
-
Cell Line:HCT-116, HCT-15, HT-29 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:72 h
-
Result:Induced a minor apoptotic response in HCT-15 and HCT-116 spheroids, with cell death levels reaching approximately 30% in HCT-15 spheroids.
Caused no significant change in apoptotic cell number (10% cell death) in HT-29 spheroids compared to untreated controls.
-
Cell Line:HCT-116, HT-29 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:48 h (cytochrome-c analysis)
72 h (cleaved caspase-3 analysis) -
Result:Caused cytochrome-c release from mitochondria into the cytosol and induced cleavage of caspase-3 in HCT-116 spheroids.
Showed less pronounced cytochrome-c release and caspase-3 cleavage effects in HT-29 spheroids.
-
Cell Line:HCT-116, HT-29 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:72 h
-
Result:Caused collapse of the punctuated plectin network into larger aggregates and reduced plectin mean fluorescence intensity (MFI) in HCT-116 spheroids.
Induced collapse of the α-tubulin microtubule network, with a 5-fold reduction in α-tubulin MFI in HCT-116 spheroids.
Disrupted the F-actin cytoskeleton, forming aggregates with reduced fluorescence signal in HCT-116 spheroids.
Showed less pronounced cytoskeletal disruption effects in HT-29 spheroids.
-
Cell Line:HT1080 human fibrosarcoma multicellular tumour spheroids
-
Concentration:40 μM
-
Incubation Time:72 h, monitored up to 144 h
-
Result:Prevented spheroid invasion into the Matrigel matrix, with treated spheroids remaining smaller and non-invasive compared to larger, invasive untreated spheroids, and this trend maintained up to 144 h.
-
Cell Line:HCT-116 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:24 h
-
Result:Induced phosphorylation of eIF2α, while total eIF2α levels remained consistent with untreated controls.
-
Cell Line:HCT-116, HCT-15, HT-29 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:24 h
-
Result:Increased CRT expression and promoted CRT translocation to the cell membrane (evidenced by colocalization with membrane marker) in HCT-116 spheroids.
Caused up to a 4-fold increase in CRT+ cells compared to untreated controls, with the highest percentage (20%) in HCT-116 spheroids and lowest responsiveness in HT-29 spheroids.
-
Cell Line:HCT-116, HT-29 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:72 h
-
Result:Increased extracellular HMGB-1 levels by approximately 5-fold in HCT-116 spheroids and approximately 3-fold in HT-29 spheroids compared to untreated controls.
Induced translocation of HMGB-1 from the nucleus to the cytoplasm and extracellular space in treated spheroids, with a stronger effect in HCT-116 spheroids.
-
Cell Line:HCT-116, HT-29 human colon carcinoma multicellular tumour spheroids
-
Concentration:200 μM
-
Incubation Time:24 h
-
Result:Increased fluorescence signals for HSP70 and HSP90, with preferred co-localization to the plasma membrane compared to untreated controls.
Chemical Information
-
CAS. Nr. 2119725-22-1
-
Molecular Weight 538.47
-
Formel C22H23Cl2FN2RuS
-
SMILES
[Cl-][Ru+2]12345([CH]6=[CH]47)([N]8=CC=CC=C8C(NC(C=C9)=CC=C9F)=[S]5)[C]6(C(C)C)=[CH]1[CH]2=[C]37C.[Cl-]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
bioRxiv
The umbrella cell keratin network: organization as a tile-like mesh, formation of a girded layer in response to bladder filling, and dependence on the plectin cytolinker. [Abstract]2024 Jun 13:2024.06.11.598498. PMID: 38915686
Protokoll
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Suspension Spheroid Formation (Low-Adhesion/Forced Aggregation)
Suspension spheroid formation by low-adhesion or forced aggregation is a scaffold-free 3D culture method in which cells are prevented from attaching to plastic and are guided to interact with each other, forming compact multicellular aggregates through cell-cell adhesion, gravity-driven settling, microwell confinement, or centrifugation-assisted aggregation. The method detects the capacity of a cell population to self-assemble into spheroids, and the main readouts are spheroid formation efficiency, morphology, compactness, projected area or diameter, circularity, viability, proliferation, and experimental responses such as drug sensitivity. Classic implementations include hanging drops, agarose or hydrogel microwells, ultra-low-attachment round-bottom wells, and centrifugation-assisted aggregation in non-adherent wells. Low-adhesion culture shifts the system away from cell-substrate adhesion and toward cell-cell adhesion, while round-bottom or microwell geometry concentrates cells into
-
Hanging Drop Spheroid Culture
Hanging drop spheroid culture is a scaffold-free 3D culture method in which a small droplet of cell suspension is inverted so that suspended cells sediment by gravity toward the lowest point of the drop, aggregate, and form a multicellular spheroid with direct cell-cell contact. Spheroids generated by this method are used to study 3D cell cohesion, cell-ECM interactions, drug response, co-culture organization, and tumor-like microenvironmental behavior. The primary readouts are spheroid formation efficiency, spheroid size, circularity or compactness, viability, and treatment response; these can be measured by bright-field microscopy, fluorescence viability staining, ATP-, fluorescence-, or colorimetric-based assays, and image-based diameter or volume calculations.
-
3D Tumor Spheroid Invasion Assay
3D tumor spheroid invasion assay measures outward tumor-cell movement from a compact multicellular spheroid into a surrounding extracellular matrix, producing image-based readouts such as invasion area, invasion distance, cell dispersion, or time-resolved cell movement. The method models tumor-cell interaction with matrix components in three dimensions and is used to study invasive phenotypes in cancer models including glioblastoma, squamous cell carcinoma, breast cancer, prostate cancer, ovarian cancer, and other solid tumor systems.
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Reinheit & Dokumentation
-
Data Sheet (303 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Plecstatin-1
- 2119725-22-1
- Plecstatin1
- Plecstatin 1
- Microtubule/Tubulin
- Eukaryotic Initiation Factor (eIF)
- HSP
- Caspase
- Reactive Oxygen Species (ROS)
- Apoptosis
- endoplasmic reticulum stress
- eukaryotic initiation factor 2-alpha
- F-actin
- HCT-116
- colorectal tumour spheroid
- integrated stress response
- plectin
- immunogenic cell death
- colon adenocarcinoma cell
- α-tubulin
- Inhibitor
- inhibitor
- inhibit